He sold the stock, then bought it back after the price crashed
In the uncertain early months of 2020, federal investigators turned their attention to a sitting senator's stock trades, asking an ancient question dressed in modern form: did the powerful use what they knew to protect what they owned? The Justice Department's inquiry into Senator David Perdue's sale of Cardlytics shares — timed before a sharp decline in the company's value — has now closed without charges, leaving the matter resolved in law but not entirely settled in the public imagination. The closure arrives as Perdue fights for his Senate seat in Georgia, a race whose outcome will help determine the balance of national power.
- A senator sold over a million dollars in stock weeks before its price collapsed, and the coincidence was too striking for federal investigators to ignore.
- Perdue's former seat on Cardlytics' board meant he had walked the corridors where the bad news was born — long before it reached the market.
- The Justice Department examined his trades alongside those of other lawmakers who moved money at the pandemic's onset, a moment of collective institutional scrutiny.
- The inquiry closed quietly — no charges, no indictment, no public explanation — leaving resolution without full transparency.
- Perdue's campaign declared vindication, framing the investigation itself as a political weapon, while his subsequent repurchase of the stock at its low raised questions that official silence could not fully answer.
- With the Georgia runoff approaching and Senate control in the balance, the absence of charges clears a path forward — though not every shadow has lifted.
In the early weeks of 2020, Senator David Perdue of Georgia sold more than a million dollars in stock in Cardlytics, a financial technology company where he had once served on the board. Six weeks later, the company's share price fell sharply — its founder announced his departure as CEO, and the firm warned that revenues would miss expectations. The timing drew scrutiny, and federal investigators opened an inquiry to determine whether Perdue had traded on inside knowledge.
The examination was serious in scope. Prosecutors considered whether Perdue's board history gave him access to internal forecasts before they became public — and whether his decision to sell reflected information the market did not yet have. If so, it would constitute insider trading under federal law.
The inquiry, however, ended quietly. No charges were filed, no settlement reached. The New York Times reported the closure in late November 2020, citing four people familiar with the matter. The Justice Department offered no public statement.
Perdue's campaign responded swiftly, calling the original accusations baseless and politically motivated. Yet the arc of his own trading complicated that framing: after the stock bottomed out during the pandemic's market panic, he bought back a significant portion of what he had sold — suggesting he believed, at the lower price, that the company's value had been underestimated. Whether that confidence rested on public or private knowledge remained, officially, an open question now formally closed.
The timing of the closure carried its own weight. Perdue was in the middle of a competitive Georgia Senate runoff — one of two races that would determine control of the chamber. Without the shadow of a federal investigation, he could campaign on clearer ground. The law had rendered its verdict. The larger questions lingered in the margins.
In the early months of 2020, as the COVID-19 pandemic began to reshape American life, Republican Senator David Perdue of Georgia sold more than a million dollars' worth of stock in Cardlytics, a financial technology firm where he had once served on the board. Six weeks later, the company's share price collapsed. The founder announced he would step down as chief executive, and the firm issued a warning that its future sales would fall short of expectations. The timing raised questions. Federal investigators opened an inquiry to determine whether Perdue had traded on material nonpublic information—whether he knew something the market did not.
The Justice Department's examination was broad in scope. Prosecutors and agents looked at Perdue's trading patterns around the onset of the pandemic, a period when many lawmakers faced scrutiny for their market moves. The senator's position on Cardlytics' board meant he would have had access to the company's internal deliberations and financial forecasts before they became public. If he had sold his shares knowing that bad news was coming, that would constitute insider trading, a federal crime.
What happened next, however, was quiet. The inquiry closed without charges. No indictment was filed. No settlement was reached. The New York Times reported the development in late November 2020, citing four people with knowledge of the case. The closure came without public announcement or explanation from the Justice Department.
Perdue's campaign seized on the outcome immediately. John Burke, the senator's communications director, released a statement characterizing the investigation's end as vindication. He called the original accusations "baseless" and "nothing more than lies to push a categorically false narrative for political gain." The framing was pointed: the inquiry itself, in this telling, had been a weapon wielded for partisan purposes.
The timeline of Perdue's own trading told a different story about his confidence in the company's prospects. After the stock price bottomed out in March—during the market's pandemic panic—he bought back a substantial portion of the shares he had sold earlier. This suggested that at the lower price, he believed the stock was undervalued. Whether that belief was based on public information or private knowledge remained, officially, a closed question.
Cardlytics declined to comment on the matter. The company itself had moved forward: its leadership transition was complete, its revised guidance was public, and its stock had resumed trading in a market that had absorbed the news. For Perdue, the timing of the inquiry's closure mattered. He was in the midst of a competitive reelection campaign in Georgia, one of two Senate races that would determine control of the chamber. The absence of charges meant he could campaign without the shadow of a federal investigation.
Citações Notáveis
The baseless accusations leveled against Senator Perdue were nothing more than lies to push a categorically false narrative for political gain— John Burke, Perdue's campaign communications director
A Conversa do Hearth Outra perspectiva sobre a história
Why would a senator's stock trades in a company where he served on the board trigger a federal investigation in the first place?
Because the timing looked suspicious. He sold over a million dollars of stock, and then six weeks later the company announced major problems—leadership change, missed forecasts. If he knew those problems were coming before he sold, that's insider trading.
But he bought the stock back later, after it crashed. Doesn't that suggest he didn't actually know what was coming?
It could suggest that. Or it could suggest he was confident the company would recover, which is different from knowing whether he had traded on inside information. The investigation would have tried to determine what he knew and when he knew it.
So why did the DOJ close it without charges?
The source doesn't say. That's the real question. Either they found no evidence of a crime, or they found evidence but decided not to prosecute, or something in between. We don't know.
And his campaign called it exonerating?
They did. But technically, no charges doesn't necessarily mean exoneration—it just means no prosecution. The distinction matters, even if politically it doesn't.